MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway

M Xu; G-L Tian; C-C Hao; M Shi; D-J Zha; K Liang

doi:10.26355/eurrev_202007_21849

MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway

Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7199. doi: 10.26355/eurrev_202007_21849.

Authors

M Xu¹, G-L Tian, C-C Hao, M Shi, D-J Zha, K Liang

Affiliation

¹ Department of Radiation Oncology, Air Force Medical University, Xi'an, Shaanxi, China.

PMID: 32706037
DOI: 10.26355/eurrev_202007_21849

Abstract

The article "MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway, by M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang, published in Eur Rev Med Pharmacol Sci 2019; 23 (12): 5215-5222. DOI: 10.26355/eurrev_201906_18186. PMID: 31298371" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18186.

Publication types

Retraction of Publication